中国医师进修杂志
中國醫師進脩雜誌
중국의사진수잡지
CHINESE JOURNAL OF POSTGRADUATES OF MEDICINE
2014年
14期
54-58
,共5页
高英%宋成洋%惠林萍%田野%田大力%邱雪杉%王恩华
高英%宋成洋%惠林萍%田野%田大力%邱雪杉%王恩華
고영%송성양%혜림평%전야%전대력%구설삼%왕은화
癌,非小细胞肺%肿瘤转移%预后%Iduna
癌,非小細胞肺%腫瘤轉移%預後%Iduna
암,비소세포폐%종류전이%예후%Iduna
Carcinoma,non-small-cell lung%Neoplasm metastasis%Prognosis%Iduna
目的 探讨E3泛素连接酶Iduna mRNA和蛋白在非小细胞肺癌组织和癌旁肺组织中的表达及其与临床病理因素和预后的关系.方法 应用反转录聚合酶链反应(RT-PCR)、Western-Blot和免疫组织化学(EnVision)方法检测分析非小细胞肺癌组织和癌旁肺组织中Iduna mRNA和蛋白的表达,并分析其与临床病理因素和预后的关系.结果 RT-PCR及Western-Blot结果显示非小细胞肺癌组织中Iduna mRNA和蛋白表达水平分别为0.468±0.086和2.554±0.544,明显高于癌旁肺组织的0.203±0.070和1.570±0.316,差异均有统计学意义(P<0.05);免疫组织化学结果显示:Iduna在肺泡上皮细胞中呈阴性,在正常支气管黏膜上皮中呈阴性或弱阳性,在非小细胞肺癌组织中呈不同程度的阳性表达.Iduna的高表达率与肿瘤分化程度呈负相关(P=0.002),与肿瘤大小(P=0.044)、TNM分期(P=0.015)、淋巴结转移(P=0.009)呈正相关,并与Ⅰ期非小细胞肺癌患者的预后有关(P=0.016).结论 Iduna的高表达可能与非小细胞肺癌的侵袭、转移过程密切相关,有可能是提示非小细胞肺癌患者预后不良的指标.
目的 探討E3汎素連接酶Iduna mRNA和蛋白在非小細胞肺癌組織和癌徬肺組織中的錶達及其與臨床病理因素和預後的關繫.方法 應用反轉錄聚閤酶鏈反應(RT-PCR)、Western-Blot和免疫組織化學(EnVision)方法檢測分析非小細胞肺癌組織和癌徬肺組織中Iduna mRNA和蛋白的錶達,併分析其與臨床病理因素和預後的關繫.結果 RT-PCR及Western-Blot結果顯示非小細胞肺癌組織中Iduna mRNA和蛋白錶達水平分彆為0.468±0.086和2.554±0.544,明顯高于癌徬肺組織的0.203±0.070和1.570±0.316,差異均有統計學意義(P<0.05);免疫組織化學結果顯示:Iduna在肺泡上皮細胞中呈陰性,在正常支氣管黏膜上皮中呈陰性或弱暘性,在非小細胞肺癌組織中呈不同程度的暘性錶達.Iduna的高錶達率與腫瘤分化程度呈負相關(P=0.002),與腫瘤大小(P=0.044)、TNM分期(P=0.015)、淋巴結轉移(P=0.009)呈正相關,併與Ⅰ期非小細胞肺癌患者的預後有關(P=0.016).結論 Iduna的高錶達可能與非小細胞肺癌的侵襲、轉移過程密切相關,有可能是提示非小細胞肺癌患者預後不良的指標.
목적 탐토E3범소련접매Iduna mRNA화단백재비소세포폐암조직화암방폐조직중적표체급기여림상병리인소화예후적관계.방법 응용반전록취합매련반응(RT-PCR)、Western-Blot화면역조직화학(EnVision)방법검측분석비소세포폐암조직화암방폐조직중Iduna mRNA화단백적표체,병분석기여림상병리인소화예후적관계.결과 RT-PCR급Western-Blot결과현시비소세포폐암조직중Iduna mRNA화단백표체수평분별위0.468±0.086화2.554±0.544,명현고우암방폐조직적0.203±0.070화1.570±0.316,차이균유통계학의의(P<0.05);면역조직화학결과현시:Iduna재폐포상피세포중정음성,재정상지기관점막상피중정음성혹약양성,재비소세포폐암조직중정불동정도적양성표체.Iduna적고표체솔여종류분화정도정부상관(P=0.002),여종류대소(P=0.044)、TNM분기(P=0.015)、림파결전이(P=0.009)정정상관,병여Ⅰ기비소세포폐암환자적예후유관(P=0.016).결론 Iduna적고표체가능여비소세포폐암적침습、전이과정밀절상관,유가능시제시비소세포폐암환자예후불량적지표.
Objective To investigate the mRNA and protein expression of E3 ubiquitin ligase Iduna in non-small-cell lung cancer tissue and para-neoplastic lung tissue,and the correlation of the Iduna expression with clinicopathological factors and prognosis.Methods The expression levels of the Iduna mRNA and protein in non-small-cell lung cancer tissue and para-neoplastic lung tissue were determined by reverse transcriptase-polymerase chain reaction (RT-PCR),Western-Blot and immunohistochemistry respectively,and the correlation of the Iduna expression with clinicopathological factors and prognosis was analyzed.Results RT-PCR and Western-Blot showed the expression levels of the Iduna mRNA and protein in non-small-cell lung cancer tissue (0.468 ± 0.086 and 2.554 ± 0.544) were significantly higher than those in para-neoplastic lung tissue (0.203 ± 0.070 and 1.570 ± 0.316),there were statistical differences (P < 0.05).Immunohistochemistry results showed that Iduna was negative expression in the alveolar epithelium cells,negative or weak positive expression in normal bronchial and positive expression in different degrees in the non-small-cell lung cancer tissue.Iduna high expression rate was negative correlation with tumor differentiation (P =0.002),Iduna high expression rate was positive correlation with large tumor size (P =0.044),TNM staging (P=0.015) and lymph node metastasis (P=0.009).Iduna high expression of I stage non-small-cell lung cancer patients was correlated with poor post-operative survival (P =0.016).Conclusions High expression of Iduna may be related to the process of invasion and metastasis of nonsmall-cell lung cancer.It is possible that Iduna serve as potential markers for predicting prognosis in nonsmall-cell lung cancer.